Inotuzumab-ozogamicinThrombocytopenia: 2 case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88245-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：426 / 426

相关论文

共 50 条

[1] Inotuzumab ozogamicinThrombocytopenia: case report
Reactions Weekly, 2019, 1734 (1) : 283 - 283
[2] Inotuzumab ozogamicinAcute cholecystitis: case report
Reactions Weekly, 2018, 1695 (1) : 221 - 221
[3] Inotuzumab-ozogamicinHepatotoxicity: case report
Reactions Weekly, 2023, 1971 (1) : 138 - 138
[4] Azacitidine/blinatumomab/inotuzumab ozogamicinVarious toxicities: 2 case report
Reactions Weekly, 2022, 1925 (1) : 102 - 102
[5] Inotuzumab ozogamicinNeurological and renal toxicity: case report
Reactions Weekly, 2019, 1745 (1) : 159 - 159
[6] Inotuzumab-ozogamicinLiver toxicity: case report
Reactions Weekly, 2022, 1889 (1) : 178 - 178
[7] Inotuzumab-ozogamicinLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 746 - 746
[8] Inotuzumab-ozogamicin/BlinatumomabNo response: case report
Reactions Weekly, 2021, 1864 (1) : 195 - 195
[9] Blinatumomab/inotuzumab-ozogamicinVarious toxicities : case report
Reactions Weekly, 2024, 2020 (1) : 106 - 106
[10] Blinatumomab/inotuzumab-ozogamicinLack of efficacy: case report
Reactions Weekly, 2021, 1861 (1) : 79 - 79

← 1 2 3 4 5 →